Skip to Content

'
Jeffrey N. Myers, M.D., Ph.D., F.A.C.S.

Present Title & Affiliation

Primary Appointment

Professor, Department of Head and Neck Surgery, Division of Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX
Ashbel Smith Professor, Department of Head and Neck Surgery, Division of Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX
Deputy Chair for Academic Programs, Department of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX
Director of Research, Department of Head and Neck Surgery, Division of Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Research Interests

Squamous cell carcinoma

Tongue neoplasms

p53 Gain of Function Mutations

Clinical Interests

Head and neck surgical oncology

Treatment of melanoma of the head and neck regions

Squamous cell carcinoma of the oral cavity

Office Address

The University of Texas M. D. Anderson Cancer Center
1515 Holcombe Blvd
Unit Number: 1445
Houston, TX 77030-4009
Room Number: FCT10.6028
Phone: 713-745-2667
Fax: 713-794-4662

Education & Training

Degree-Granting Education

1991 University of Pennsylvania School of Medicine, Philadelphia, PA, MD, Medicine
1991 University of Pennsylvania School of Medicine, Philadelphia, PA, PHD, Biochemistry
1983 University of Pennsylvania, Philadelphia, PA, BA, Biochemistry

Postgraduate Training

1/1996-12/1997 Fellowship, Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX
1/1992-12/1996 Residency, Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA

Board Certifications

1/1997 American Board of Otolaryngology

Experience/Service

Academic Appointments

Professor, Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 1/2006-present

Honors and Awards

2008-2013 Ashbel Smith Professorship, The University of Texas M. D. Anderson Cancer Center
2005-2009 America’s Top Doctors for Cancer
2004 Julie and Ben Rogers Award for Excellence in Patient Care
2003-2008 Best Doctors in America

Professional Memberships

American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF)
Member, 1/1993-present
American Association for Cancer Research
Member, 1/1996-present
American Board of Otolaryngology, Chicago, IL
Guest Examiner, 4/2007-4/2008
American Head and Neck Society (AHNS)
Member, 1/2000
American Medical Association
Member, 1/1993-present
American Society of Clinical Oncology (ASCO)
Member, 1/1995-present
Graduate School of Biomedical Sciences, Houston, TX
Member, 9/2002-8/2010

Selected Publications

Peer-Reviewed Original Research Articles
1. Choi S, Sano D, Cheung M, Zhao M, Jasser SA, Ryan AJ, Mao L, Chen W-T, El-Naggar AK, Myers JN. Vandetanib (ZD6474), an inhibitor of the vascular endothelial growth factor and epidermal growth factor receptors inhibits the growth of adenoid cystic carcinoma in an orthotopic nude mouse model. Clinical Cancer Research 14(16):5081-9, 8/2008.
2. Zhou G, Xie TX, Zhao M, Jasser SA, Younes MN, Sano D, Lin J, Kupferman ME, Santillan AA, Patel V, Gutkind JS, El-Naggar AK, Emberley ED, Watson Ph, Matsuzawa SI, Reed JC, Myers JN. Reciprocal negative regulation between S100A7/psoriasin and beta-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity. Oncogene 5(27(25)):3527-38, Jun, 6/2008. e-Pub 1/2008.
3. Kim S, Yazici YD, Calzada G, Wang ZY, Younes MN, Jasser SA, El-Naggar AK, Myers JN. Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice. Mol Cancer Ther 6:1785-92, 6/2007.
4. Kupferman ME, Patel V, Sriuranpong V, Amornphimoltham P, Jasser SA, Mandal M, Zhou G, Wang J, Coombes K, Multani A, Pathak S, Silvio Gutkind J, Myers JN. Molecular analysis of anoikis resistance in oral cavity squamous cell carcinoma. Oral Oncol, 9/2006. PMID: 16978912.
5. Younes MN, Yazici YD, Kim S, Jasser SA, El-Naggar AK, Myers JN. Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with NVP-AEE788 for the treatment of aggressive follicular thyroid cancer. Clin Cancer Res 12:3425-34, 6/2006. PMID: 16740767.

Grant & Contract Support

Title: Progression and Metastasis of Oral Tongue Cancer
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 4/1/2009 - 3/31/2014
 
Title: Molecular Epidemiology of Head and Neck Cancer
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Wei
Duration: 3/1/2008 - 2/28/2013
 
Title: Acoustic Imaging of Sentinel Node Metastasis Using Plasmonic Nanosensors
Funding Source: NIBIB
Role: Co-Investigator
Principal Investigator: Sokolov/Emelianov
Duration: 9/1/2007 - 8/31/2011
 
Title: Research Training in Otolaryngology-Head and Neck Surgery
Funding Source: NIH/NIDCD
Role: Co-Investigator
Principal Investigator: Brownell
Duration: 7/1/2005 - 6/30/2010
 
Title: MD Anderson Cancer SPORE in Head and Neck - (CDP)
Funding Source: NIH/NCI
Role: Co-Program Leader
Principal Investigator: Lippman
Duration: 9/22/2002 - 7/31/2013
 
Title: M.D. Anderson Cancer Center SPORE in Head and Neck Cancer-Project 3
Funding Source: NIH
Role: Co-Investigator
Principal Investigator: Lippman
Duration: 9/22/2002 - 7/31/2009
 
Title: Training of Academic Head and Neck Surgical Oncology
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 8/1/1995 - 6/30/2011

Last updated: 9/21/2009